May 14 (Reuters) - French drugmaker Sanofi

said on Wednesday it plans to invest at least $20 billion in the

United States through 2030, which includes an increase in

research and development spending and the allocation of billions

of dollars to US manufacturing.

The announcement makes Sanofi the latest drugmaker to

announce large-scale U.S. investments in response to Trump's

push to onshore pharmaceutical manufacturing.